Suresh Kumar M.D. is Triple Board Certified Brain Injury Specialist, Neurologist & Director of Headaches, TBI & Memory Research Institute in Southern USA. He completed residency training in Neurology from LSU and later board certification in Headaches Medicine & Traumatic Brain Injury Medicine. He is User Interface Software Architect; Neuro Scientist & Clinician operating research based clinical practice. He has invented and patent rights owner of Life Integrated Cognitive Computerized Application (LICCA). His patients are undergoing online cognitive therapy for memory loss monitored from his own office Regain Memory Center. He has helped more than 50 patients with memory impairment after TBI, and mild to moderate dementia under Regain Memory 360 protocol approach.He has published and presented many abstracts and papers on diagnosis,treatment of mild traumatic brain injury and cognitive deficit.

TBI, Neurology , mild traumatic brain injury, late post-traumatic seizures, post-traumatic headaches,cognitive loss, plasticity and remediation.

Dr. Rosi is an Associate Professor in the Departments of Physical Therapy and Rehabilitation Science and Neurological Surgery; she is also the Director of Neurocognitive Research in the Brain and Spinal Injury Center (BASIC). Her areas of expertise include neuroinflammation, brain injury and cognitive functions. She obtained her PhD from the University of Florence, Italy. After completing a short Post-Doctoral Training in Italy she moved to the University of Arizona for a Post-Doctoral Research Associate position in the Neural System Memory and Aging Center under the guidance of Drs. Carol Barnes and Gary Wenk. She joined the UCSF faculty in 2006 and she received an accelerated promotion to Associate Professor in 2011 and became Director of Neurocognitive Research. She has been able to build national and international recognition in the field of Neuroscience, and among her numerous achievements she recently received the Bridging the Gap Award from the California Institute for Quantitative Bioscience (2015) and was chosen to give the 2015 Discovery Talk at the upcoming UCSF Alumni Weekend.

Neuroinflammation Traumatic brain injury Therapeutic cranial irradiation and cognition Space irradiation and cognition Innate immune system and cognition Synaptic plasticity, hippocampal learning and memory Plasticity-related immediate early gene Arc (activity regulated cytoskeleton-associated protein) Tumor Necrosis Factor-(TNF-α), learning and memory Prefrontal cortex injury and cognitive functions

Robert Friedlander, MD, MA, became the fourth chair in the department’s history. Prior to joining the department, Dr. Friedlander was professor of neurosurgery at Harvard Medical School and vice-chairman of neurosurgery and associate director of cerebrovascular surgery at Brigham and Women’s Hospital in Boston.

Aneurysms, vascular malformations, brain tumors, carotid disease, cerebrovascular disease, Chiari malformation, spinal cord tumors. Research focuses on mechanisms of apoptosis, Huntington’s disease, ALS, and stroke.

He is research at American Spine and Director General of the Federal Hospital of State Servers at the General Director of the Hospital. He is Former Physician at Multidisciplinary Center for Pain ,Former Physician at Ministry of Health - HFSE and Former Physician at Neurosurgery Former Physician at Forensic Medicine. He is also Former Physician at SBED - Brazilian Society for the Study of Pain

Spin, neurosurgery, pain

Pant received his M.A. and Ph.D. degrees in Physics from Agra University, Agra, India. His postdoctoral studies were conducted on the mechanisms of electron and ion transport in model membrane systems at the Department of Biophysics at Michigan State University. He joined the Laboratory of Neurobiology in the NIMH as a senior staff fellow in 1974 with Dr. Ichiji Tasaki where he studied the function of the axonal cytoskeleton in the squid giant axon. In 1979 he moved to the NIAAA extending his studies on the neuronal cytoskeleton and the effects of alcohol on its regulation. Dr. Pant moved to the NINDS, Laboratory of Neurochemistry in 1987 where he is presently chief of the section on Cytoskeleton Regulation. His laboratory is studying the mechanisms of topographic regulation of neuronal cytoskeleton proteins by post-translational modification, including the role of kinase cascades in normal brain and during neurodegeneration.

Parkinsion’s and Alzheimer’s Diseases

Dr. Aguinaldo Pereira Catanoce is currently working as a Director in the University Hospital Technical Puc Campinas at Sao Paulo, Brazil. 1. Neurosurgeon Doctor With Expertise In Brain Tumors In areas Vascular Diseases, Surgery The Spine and Peripheral Nerves. Specializing In Video Endoscopic Surgeries For nervous system tumors, mostly Pituitary lesions 2. Medical Doctor In Neurosurgery. Especialized In Brain Tumors, Vertebral, Periferic Nerves And Vascular Desiese. Endoscopic Pituitary Adenomas For Video Neurosurgery And Ventricular Lesion 3. Expertise in Private Hospitals of. Assistant Team Neurosurgery From Vera Cruz Campinas Hospital, Campinas From From Puc Hospital and State Hospital Sumaré 4. Manager Administrative Medical. Manager Sector From Medical SADT Do Puc Campinas From Hospital. Manager Responsible For Medical Radiology In areas, hemodynamics, pathology, LAC, Endoscopy, Dialysis, Oncology Multidisciplinary Team and Hearing Health 5. Medical Manager Of Radiologic And therapeutic Area Of pontificie University Catolic Of Campinas Hospital. Oncology, Hemodialysis, Hemodinamic And Clinic Laboratory Medical Doctor Manager 6. Teacher of Medicine University Catolic Of Campinas, Brazil 7. Member of the Brazilian Society HOLDER Neurosurgery

Brain Tumors, Neurosurgery, Vascular Diseases, Spine and Spinal Disorders, Neurology

Professor WK Tang was appointed to professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. His main research areas are Addictions and Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong. Research Interest

Geriatric Psychiatry, Addictions and Neuropsychiatry and Stroke Disorders

Dr. Bielekova received an M.D. degree in 1993 from Comenius University in Bratislava, Slovakia. After a medical internship at SUNY Downstate, Medical Center in Brooklyn and a neurology residency at the Boston University, she did 3 year postdoctoral research fellowship at the NIH/NINDS/Neuroimmunology Branch (NIB). She remained at NIB for additional 5 years as staff physician, focusing on development of novel therapies for multiple sclerosis (MS). In 2005 she became associate professor of neurology and director of the Waddell Center for MS at University of Cincinnati. In 2008 she moved back to NINDS as an investigator. Her laboratory is studying mechanisms of immunoregulation in humans and mechanisms of tissue injury in neuroimmunological diseases, such as MS. In addition, Dr. Bielekova is in charge of the clinical service of the Neuroimmunology Branch and is principal investigator on several innovative Phase I/II clinical trials and natural history protocols.

Neuroimmunological Diseases Unit (NDU) has two major areas of interest: First, we study mechanisms of immunoregulation in humans with special emphasis on immunoregulatory natural killer (NK) cells and IL-2/IL-2R system. We are investigating mechanisms that maintain immune tolerance (i.e. mechanisms that assure that immune system does not attack normal tissue) in healthy human subjects and in patients with multiple sclerosis (MS) a putative autoimmune disorder of the central nervous system (CNS). Second, we are interested to define targets of the immune response in neuroimmunological diseases, mechanisms that participate in CNS tissue destruction and to define in-vivo biomarkers that reflect prevailing mechanisms of CNS tissue injury in neuroimmunological diseases. Our laboratory focuses on human subjects and extensive functional in-vitro studies are complemented with in-vivo observations derived from Phase I/II clinical trials that target pathways/molecules of interest defined in the laboratory. This allows us to correlate therapy-induced changes on the immune system functions to neuroimaging and functional measures of neurological disability, providing in-vivo relevance for the observed biological alterations. Our long-term goal is to develop novel, potentially curative immunomodulatory therapies for MS and to develop neuroprotective strategies for neuroimmunological diseases. Furthermore, we strive to define and validate biomarkers indicative and predictive of therapeutic response to different treatment modalities.

Dr. Rong Fu Wang as Chief physician, Doctoral supervisor, is the Director and professor of Nuclear Medicine Department of Peking University Health Science Centre and Peking Univerisity First Hospital. He is a physician trained in France & with 6 years of experience in research, academic and clinical practice of diagnostic and therapeutic nuclear medicine. He got MD(Nuclear medicine) from Paris V, France in 1992, and Ph.D.(pharmacology) from Toulouse III, France in 1995. As editor in the Textbook of Nuclear Medicine, J Labeled Immuno & Clinic, Chin Cancer Imaging, et al., he is senior most faculty with Peking University in nuclear medicine with about 300 publications, 12 books, 8 Grants, 4 patents, “Honorary Award” from the Society of Nuclear Medicine in the USA in 1994. “Noninvasive Imaging of Human Telomerase Reverse Transcriptase (hTERT) Messenger RNA with 99mTcRadiolabeled Antisense Probes in Malignant Tumor” has received Editors’ Choice Award for one of the three best basic science manuscripts published in The Journal of Nuclear Medicine in 2007. Now he is member of SNM, EANM, Country Principals of China in ASNM, Vice President of Chinese Society of Nucl Med Equipment and Techniques, and Vice President of Nuclear Medicine and Molecular Imaging in Beijing.

His special interest is in Nanomolecaular Imaging, Neuroreceptor and neurotransmission imaging, Nuclear Cardiology, Quality control of clinical muclear medicine and labeled compounds and radiopharmaceuticals.

Ivan Gospodinov Milanov is Director & Professor at the University Neurological Hospital “St. Naum”, Department of Movement Disorders in Bulgaria. He is a President of the Bulgarian Neurological Society, Bulgarian Movement Disorders and Multiple Sclerosis Society, Bulgarian Headache and Pain Society etc. Dr. Milanov has published 400 scientific publications & 18 monographs, 24 Handbooks of Neurology. His Research interest includes movement disorders, multiple sclerosis, headache, pain, and clinical electromyography.

Movement disorders, Multiple sclerosis, Headache, Pain, and Clinical electromyography.